Viracor Eurofins BioPharma Services Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Viracor Eurofins BioPharma Services's estimated annual revenue is currently $21.3M per year.(i)
  • Viracor Eurofins BioPharma Services's estimated revenue per employee is $201,000

Employee Data

  • Viracor Eurofins BioPharma Services has 106 Employees.(i)
  • Viracor Eurofins BioPharma Services grew their employee count by 7% last year.

Viracor Eurofins BioPharma Services's People

NameTitleEmail/Phone
1
VP, Research & DevelopmentReveal Email/Phone
2
VP Operations and General Manager BioPharmaReveal Email/Phone
3
DirectorReveal Email/Phone
4
Director Marketing, BioPharma ServicesReveal Email/Phone
5
Director, Financial PlanningReveal Email/Phone
6
Project ManagerReveal Email/Phone
7
Project ManagerReveal Email/Phone
8
Biopharma Support Services ManagerReveal Email/Phone
9
Account ManagerReveal Email/Phone
10
Executive ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6830.1M212385%N/AN/A
Add Company

What Is Viracor Eurofins BioPharma Services?

Viracor Biopharma Services is an integrated arm of Eurofins, offering complex/esoteric testing across multiple phases of drug development. For more than 30 years, Viracor has been dedicated to helping biopharma clients by providing high quality, accurate results in the areas of molecular infectious disease testing, immunogenicity, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing. We provide specialized expertise in complex assay design, optimization, transfer and validation, customized to our clientᅢᄁ¬ツᆲ¬トᄁs needs. In addition to over 2,800 validated tests, we also accept a broad range of specimen types available on over 16 different platforms and state-of-the-art technologies, to offer maximum versatility to adapt to the unique needs of your study.

keywords:N/A

N/A

Total Funding

106

Number of Employees

$21.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Viracor Eurofins BioPharma Services News

2022-04-17 - Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Viracor and Cornell University signed an exclusive agreement ... Genetic Testing Service in Vietnam, and in BioPharma services with...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.5M10723%N/A
#2
$18.7M107-5%N/A
#3
$35M141-4%N/A
#4
$23.8M14416%N/A
#5
$15M1487%N/A